by North Woods | Mar 24, 2026 | Blog, Perspectives
By Jenni Le, Principal, Venture Investors Health Fund A patient suspected of sleep apnea used to spend the night in a lab, hooked up to sensors, trying to sleep in an unfamiliar environment, often producing a poor representation of a typical night. Today, that same...
by North Woods | Mar 4, 2026 | Blog, Perspectives
By Paul Weiss, PhD, Partner at Venture Investors Health Fund In breast cancer, there was a moment when outcomes changed dramatically, but only for certain patients. Herceptin, an antibody therapy, was developed to target an overexpression of the HER2 protein. If a...
